Related references
Note: Only part of the references are listed.Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
W. J. Heinz et al.
ANNALS OF HEMATOLOGY (2017)
ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
Alexandre Alanio et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-beta-D-glucan for invasive fungal infection: Focus on cutoff levels
Song He et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2015)
British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases
Silke Schelenz et al.
LANCET INFECTIOUS DISEASES (2015)
Understanding Bland Altman analysis
Davide Giavarina
BIOCHEMIA MEDICA (2015)
Automation of serum (1→3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia
Florian Prueller et al.
MEDICAL MYCOLOGY (2014)
Accuracy of beta-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis
D. E. Karageorgopoulos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Comparison of (1→3)-β-D-Glucan, Mannan/Anti-Mannan Antibodies, and Cand-Tec Candida Antigen as Serum Biomarkers for Candidemia
Juergen Held et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients
O. Marchetti et al.
BONE MARROW TRANSPLANTATION (2012)
ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures
M. Cuenca-Estrella et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Diagnostic Accuracy of Serum 1,3-beta-D-Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis
Akira Onishi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
β-D-Glucan kinetics for the assessment of treatment response in Pneumocystis jirovecii pneumonia
J. Held et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Serum (1→3)-β-D-glucan measurement as an early indicator of Pneumocystis jirovecii pneumonia and evaluation of its prognostic value
J. Held et al.
CLINICAL MICROBIOLOGY AND INFECTION (2011)
Clinical viability of Fungitell, a new (1→3)-β-d-glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan
Koichiro Yoshida et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2011)
Pneumocystis jirovecii infection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility
Malcolm A. Finkelman
CRITICAL REVIEWS IN MICROBIOLOGY (2010)
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality
M Morrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia
HH Larsen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Detection of Pneumocystis carinii DNA in patients with chronic lung diseases
M Probst et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)
Share Paper
